Senotherapy: Implications for Transplantation

Area of Science:

• Gerontology and Regenerative Medicine
• Cell Biology and Molecular Medicine
• Transplantation Science

Background:

• Cellular senescence is implicated in age-related organ dysfunction and disease.
• Targeting senescent cells shows potential to counteract aging effects and restore repair capacity.
• Senolysis, the elimination of senescent cells, is a promising strategy for age-related pathologies.

Purpose of the Study:

• To review senotherapeutic approaches and their mechanisms of action.
• To explore the application of senotherapies in organ transplantation.
• To discuss how pre-transplant conditioning can mitigate senescence in donor organs.

Main Methods:

• Discussion of senolytic drugs that induce apoptosis in senescent cells.
• Explanation of senomorphic drugs that modulate the inflammatory profile of senescent cells.
• Analysis of senescent cell clearance in the context of immunosuppression during transplantation.

Main Results:

• Senolytics selectively eliminate senescent cells, while senomorphics modify their inflammatory secretions.
• Reduced natural clearance of senescent cells may occur in transplant recipients due to immunosuppression.
• Pre-conditioning donor organs can reduce senescence accumulation, potentially improving transplant outcomes.

Conclusions:

• Senotherapeutics offer novel strategies to combat age-related diseases by targeting cellular senescence.
• Senotherapies hold significant potential for application in organ transplantation to improve graft function and recipient health.
• Interfering with senescence in donor organs before transplantation may reduce the burden of comorbidities in recipients.